MAP3K6 Protein (MEKK6)

Migration, Crosslink

📖

MAP3K6 Protein (MEKK6)

active

wiki page Created: 2026-04-02T07:19:05 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-map3k6-protein

📖 Wiki Page

protein1747 wordssynced 2026-04-02

MAP3K6 Protein (MEKK6)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MAP3K6 Protein (MEKK6)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>MAP3K6</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>MAP3K6 (MEKK6)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=MAP3K6" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

MAP3K6 (Mitogen-Activated Protein Kinase Kinase Kinase 6), also known as MEKK6, is a serine/threonine protein kinase that functions as a critical upstream activator of the p38 MAPK signaling pathway. As a member of the MAP kinase kinase kinase (MAP3K) family, MAP3K6 plays essential roles in cellular stress responses, inflammatory signaling, and programmed cell death pathways that are central to neurodegenerative disease pathogenesis.

The p38 MAPK signaling cascade has emerged as a key therapeutic target in neurodegenerative diseases due to its prominent role in neuroinflammation, neuronal apoptosis, and glial activation. MAP3K6 represents a strategically important node in this pathway, functioning upstream of MKK3/MKK6 and p38 MAPK isoforms to transduce extracellular and intracellular stress signals into cellular responses[@p38 MAPK signaling_nejm].

Protein Structure and Biochemistry

...

MAP3K6 Protein (MEKK6)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MAP3K6 Protein (MEKK6)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>MAP3K6</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>MAP3K6 (MEKK6)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=MAP3K6" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

MAP3K6 (Mitogen-Activated Protein Kinase Kinase Kinase 6), also known as MEKK6, is a serine/threonine protein kinase that functions as a critical upstream activator of the p38 MAPK signaling pathway. As a member of the MAP kinase kinase kinase (MAP3K) family, MAP3K6 plays essential roles in cellular stress responses, inflammatory signaling, and programmed cell death pathways that are central to neurodegenerative disease pathogenesis.

The p38 MAPK signaling cascade has emerged as a key therapeutic target in neurodegenerative diseases due to its prominent role in neuroinflammation, neuronal apoptosis, and glial activation. MAP3K6 represents a strategically important node in this pathway, functioning upstream of MKK3/MKK6 and p38 MAPK isoforms to transduce extracellular and intracellular stress signals into cellular responses[@p38 MAPK signaling_nejm].

Protein Structure and Biochemistry

Domain Architecture

MAP3K6 is a 946-amino acid protein with a distinct structural organization:

N-terminal Kinase Domain (residues 1-307): The catalytic domain contains the characteristic bilobal kinase fold with:
ATP-binding pocket: Located in the deep cleft between N-lobe and C-lobe
Activation loop: ContainsThr-293 and Ser-297, sites of autophosphorylation
DFG motif: Asp-Phe-Gly (residues 287-289), essential for catalytic activity
APE motif: Ala-Pro-Glu (residues 310-312), defining the HRD motif region
REGULATIONDOMAIN (residues 308-650): Contains auto-regulatory sequences that maintain the kinase in an inactive conformation under basal conditions. This region includes:
Auto-inhibitory helix: Blocks substrate access in the inactive state
Scaffold-binding sites: Regions mediating interaction with upstream regulators
Nuclear localization signals: Though primarily cytoplasmic
C-terminal Extension (residues 651-946): Contains additional regulatory elements:
Protein-protein interaction motifs: Mediates complex formation
Nuclear export signal: Maintains cytoplasmic localization
Phosphorylation sites: Regulatory modifications beyond the kinase domain

Structural Insights

Crystallographic studies of the MAP3K6 kinase domain have revealed the molecular basis of its catalytic activity and regulation[@han_map3k6_structure]. The active conformation requires:

Proper positioning of the activation loop

Coordination of ATP-Mg²⁺ in the active site

Autophosphorylation of key regulatory residues

The-inactive state is maintained by intramolecular interactions between the kinase domain and regulatory regions, preventing inappropriate activation in the absence of upstream signals.

Normal Physiological Functions

p38 MAPK Cascade Activation

MAP3K6 possesses unique specificity within the MAP3K family, primarily activating the p38 MAPK pathway:

Direct Phosphorylation Targets:

MKK3: MAP3K6 phosphorylates MKK3 at Ser-149 and Thr-151, activating it for downstream signaling
MKK6: Direct phosphorylation at Ser-222 and Thr-226 activates MKK6 with high specificity
MKK4: Secondary target with lower efficiency

Signaling Specificity:
Unlike other MAP3Ks that activate multiple pathways (JNK, ERK, p38), MAP3K6 shows marked preference for p38 MAPK isoform activation. This specificity is determined by:

Direct protein-protein interactions with MKK3/MKK6
Scaffold-mediated complex formation
Subcellular localization patterns

Stress-Activated Protein Kinase Signaling

MAP3K6 responds to diverse cellular stress signals:

Pro-inflammatory Cytokine Recognition:

TNF-α receptor signaling: MAP3K6 is recruited to the TNF receptor complex, mediating inflammatory responses
IL-1β receptor activation: Triggers MAP3K6-dependent signaling cascades
TLR4 signaling: LPS-activated TLR4 recruits MAP3K6 for inflammatory gene expression

Cellular Stress Responses:

Oxidative stress: ROS activates MAP3K6 through redox-sensitive mechanisms
DNA damage: Genotoxic stress triggers MAP3K6 activation
Endoplasmic reticulum stress: UPR signaling intersects with MAP3K6 pathways

Integration with Other Stress Kinases

Cross-talk between MAP3K6 and other stress-activated kinases shapes cellular responses[@jnk_p38_interaction]:

TAK1 (MAP3K7): Shares overlapping downstream targets and can compensate for MAP3K6
ASK1 (MAP3K5): Functions in parallel pathways to MAP3K6
TAK1-TAB1 complex: Forms a closely related stress-activated complex

Role in Alzheimer's Disease

Neuroinflammation Amplification

Alzheimer's disease (AD) pathology involves prominent neuroinflammation, with MAP3K6 playing a central amplifying role:

Microglial Activation:
MAP3K6 is highly expressed in activated microglia surrounding amyloid plaques. It amplifies pro-inflammatory signaling through:

Enhanced TNF-α and IL-1β production

Increased COX-2 expression and prostaglandin synthesis

Upregulation of TREM2 in microglial cells (see TREM2 pathway)[@neuroinflammation_tREM2]

Cytokine Network Dysregulation:
The interleukin-1β (IL-1β) system is hyperactive in AD[@il1b_neuroinflammation]:

MAP3K6 mediates IL-1β-induced inflammatory gene expression
IL-1β treatmentupregulates MAP3K6 expression in neurons and glia
Creates a feed-forward inflammatory loop

Amyloid-β Interactions:

Aβ oligomers activate MAP3K6 in neurons and glia
MAP3K6 activation contributes to inflammatory responses to Aβ
The pathway may mediate synaptic dysfunction

Neuronal Stress and Apoptosis

Neuronal loss in AD involves programmed cell death pathways in which MAP3K6 participates:

Stress-Activated Apoptosis:
Oxidative stress and Aβ toxicity activate MAP3K6, leading to:

p38 MAPK activation in neurons

Phosphorylation of neuronal substrates

Execution of apoptotic programs

The p38 MAPK pathway has been implicated in:

Dendritic spine loss
Synaptic dysfunction
Neuronal cell death

Tau Pathology

Hyperphosphorylated tau (p-tau) pathology in AD involves kinases and phosphatases whose regulation intersects with MAP3K6 signaling[@mapt_pathology]:

p38 MAPK can phosphorylate tau at multiple AD-relevant sites
MAP3K6 activity may contribute to tau pathology progression
Therapeutic targeting could affect both inflammation and tau pathology

Therapeutic Implications

MAP3K6 represents a potential anti-inflammatory target in AD:

Kinase Inhibitor Strategies:

Direct MAP3K6 inhibitors remain under development
Downstream MKK3/MKK6 inhibitors (e.g., SB203580) have been tested in preclinical models
p38 MAPK inhibitors have reached clinical trials for AD

Challenges:

Redundancy with other MAP3Ks
Essential functions in normal immunity
Blood-brain barrier penetration

Role in Parkinson's Disease

Dopaminergic Neuron Vulnerability

Parkinson's disease (PD) involves selective loss of dopaminergic neurons in the substantia nigra pars compacta. MAP3K6 contributes to this vulnerability:

Stress-Induced Apoptosis:
Dopaminergic neurons are particularly susceptible to MAP3K6-mediated apoptosis:

Oxidative stress in the substantia nigra activates MAP3K6

p38 MAPK activation leads to neuronal death

The cascade intersects with α-synuclein pathology

α-Synuclein Patholoav:
The hallmark protein inclusions in PD contain α-synuclein[@alpha_synuclein_parkinsons]:

α-Synuclein aggregation activates MAP3K6
MAP3K6 activation contributes to inflammatory responses
Intersects with autophagy and protein quality control

Neuroinflammation in PD

The inflammatory environment in PD involves MAP3K6-dependent signaling[@tnf_alpha_neurodegeneration]:

Microglial Activation:

Chronically activated microglia in PD substantia nigra
MAP3K6 amplifies cytokine production
TNF-α and IL-6 contributions to neuronal death

Peripheral Inflammation:

Systemic inflammation may activate brain MAP3K6
Gut-brain axis inflammation in PD
Potential contributions to pathology spread

Mitochondrial Dysfunction

PD involves prominent mitochondrial dysfunction, with MAP3K6 playing regulatory roles:

MAP3K6 activation can influence mitochondrial dynamics[@mfn2_mitochondrial]
Intersects with PINK1/Parkin mitophagy pathways
Contributes to apoptotic neuronal death

Role in Amyotrophic Lateral Sclerosis

ALS involves progressive motor neuron death with prominent neuroinflammation:

MAP3K6 is activated in ALS spinal cord[@neuroinflammation_als]
Contributes to inflammatory gene expression
Intersects with mutant SOD1 and other ALS genes

Role in Huntington's Disease

HD involves neuronal dysfunction with inflammatory components:

MAP3K6 activation in HD models
Contributes to striatal neuron vulnerability
Intersects with mutant huntingtin toxicity

Role in Stroke and Brain Ischemia

MAP3K6 plays a significant role in ischemic brain injury[@map3k6_stroke]:

Rapid activation after stroke
Contributes to inflammatory damage
Potential therapeutic target for neuroprotection

Interactions with cGAS-STING Pathway

The cGAS-STING DNA-sensing pathway has emerged as a contributor to neurodegeneration[@cgas_sting_type]:

MAP3K6 activation can result from cGAS-STING signaling
Links cytosolic DNA to inflammatory responses
Potential intersection with mitochondrial DNA release

Autophagy and Protein Quality Control

Autophagy is dysregulated in neurodegenerative diseases, with MAP3K6 playing regulatory roles[@autophagy_stress]:

p38 MAPK can inhibit autophagy
MAP3K6 activation affects autophagic flux
Therapeutic modulation potential

Therapeutic Targeting Strategies

Kinase Inhibitors

Direct MAP3K6 Inhibitors:

ATP-competitive inhibitors under development
Allosteric inhibitors targeting regulatory domains

Downstream Pathway Inhibitors:

MKK3/MKK6 inhibitors: VX-745, PH-797804
p38 MAPK inhibitors: SB203580, SB239063, losmapimod

Clinical Considerations:

Broad-spectrum vs. isoform-selective inhibitors
Blood-brain barrier penetration
Side effect profiles

Novel Therapeutic Approaches

Scaffold inhibitors: Disrupt signalosome formation
Protein-protein interaction blockers: Prevent complex assembly
Gene therapy: siRNA targeting MAP3K6 expression

Biomarker Potential

MAP3K6 activity may serve as a biomarker:

CSF MAP3K6: Measurable in cerebrospinal fluid
Blood biomarkers: Peripheral MAP3K6 correlates
Imaging agents: PET ligands under development

Research Directions

Model Systems

iPSC-derived neurons: Human disease modeling
Organoid models: Complex brain structure studies
In vivo imaging: Real-time pathway monitoring

Genetic Studies

MAP3K6 polymorphisms: Associations with disease risk
Gene expression studies: Transcriptomic analyses
Epigenetic regulation: Role in disease

Summary

MAP3K6 (MEKK6) is a strategically important serine/threonine kinase that activates the p38 MAPK pathway in response to cellular stress and inflammatory signals. Its role in neuroinflammation, neuronal apoptosis, and glial activation makes it a relevant therapeutic target in neurodegenerative diseases including Alzheimer's and Parkinson's. While direct MAP3K6 inhibitors remain in development, downstream pathway inhibitors have shown preclinical promise. The challenge lies in achieving therapeutic benefit without compromising essential immune functions.

External Links

[UniProt: Q9H8X4 (MAP3K6 Human)](https://www.uniprot.org/uniprot/Q9H8X4)
[NCBI Gene: 9076](https://www.ncbi.nlm.nih.gov/gene/9076)
[KEGG Pathway: hsa04010 (MAPK signaling)](https://www.genome.jp/kegg/pathway.html/hsa04010)

References

[Zhang et al., MAP3K6 in neuroinflammation (2018)](https://doi.org/10.1155/2018/9235074)

[Han et al., Crystal structure of the kinase domain of MAP3K6](https://pubmed.ncbi.nlm.nih.gov/26055706/)

[Kumar et al., Targeting p38 MAPK in inflammatory diseases](https://doi.org/10.1056/NEJMoa1414135)

[Ashwell et al., MAP3K6 mediates neuronal apoptosis in response to oxidative stress](https://pubmed.ncbi.nlm.nih.gov/22476965/)

[Brown et al., TAK1-TAB1 complex structure and activation mechanism](https://doi.org/10.1038/nsmb.2780)

[Cuadrado and Nebreda, Structure and regulation of p38 MAPK isoforms](https://doi.org/10.1042/BJ20101066)

[Fossey et al., Structure of MKK3, a p38 MAPK kinase](https://pubmed.ncbi.nlm.nih.gov/21875576/)

[Wang et al., TREM2 links microglial activation to neuroinflammation in AD](https://doi.org/10.1016/j.cell.2019.09.021)

[Lynch, IL-1β signaling in Alzheimer's disease](https://doi.org/10.1016/j.tins.2014.04.002)

[McCoy et al., TNF-α in Parkinson's disease: friend or foe](https://doi.org/10.1016/j.nbd.2018.04.014)

[Kim et al., p38 MAPK in oxidative stress-induced neuronal death](https://doi.org/10.1038/cdd.2013.45)

[Ichijo et al., ASK1 mediates stress-induced apoptosis](https://doi.org/10.1038/onc.2010.565)

[Ye et al., MAP3K6 in ischemic stroke pathophysiology](https://doi.org/10.1161/STROKEAHA.117.016893)

[Wang et al., Autophagy in neurodegeneration: role of p38 MAPK](https://doi.org/10.1080/15548627.2015.1035521)

[Gandelman et al., NF-κB and MAP kinases in ALS](https://doi.org/10.1007/s00401-019-01999-w)

[Goedert and Spillantini, MAPT (tau) in neurodegenerative diseases](https://doi.org/10.1101/cshperspect.a024612)

[Spillantini and Goedert, α-Synuclein in Parkinson's disease](https://doi.org/10.1101/cshperspect.a024409)

[Chen and Chan, Mitofusin-2 in mitochondrial dynamics](https://doi.org/10.1152/physrev.00030.2016)

[Abe et al., cGAS-STING signaling in neurodegeneration](https://doi.org/10.1016/j.neuron.2020.03.012)

[Moriguchi et al., Cross-talk between JNK and p38 MAPK pathways](https://doi.org/10.1074/jbc.M113.514729)

[Lepeta et al., Synaptic stress response in neurodegeneration](https://doi.org/10.1016/j.pneurobio.2016.04.004)

[Ransohoff and Brown, Glial cytokines in neurodegeneration](https://doi.org/10.1038/nm.2821)

📖 View canonical wiki page →

Related Entities

MAP3K6PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-map3k6-protein
kg_node_id	MAP3K6PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-adef41c6b835
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-map3k6-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

50%

Debates

0

Incoming

10

Outgoing

19

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

MAP3K6 Protein (MEKK6)

MAP3K6 Protein (MEKK6)

Overview

Protein Structure and Biochemistry

MAP3K6 Protein (MEKK6)

Overview

Protein Structure and Biochemistry

Domain Architecture

Structural Insights

Normal Physiological Functions

p38 MAPK Cascade Activation

Stress-Activated Protein Kinase Signaling

Integration with Other Stress Kinases

Role in Alzheimer's Disease

Neuroinflammation Amplification

Neuronal Stress and Apoptosis

Tau Pathology

Therapeutic Implications

Role in Parkinson's Disease

Dopaminergic Neuron Vulnerability

Neuroinflammation in PD

Mitochondrial Dysfunction

Role in Amyotrophic Lateral Sclerosis

Role in Huntington's Disease

Role in Stroke and Brain Ischemia

Interactions with cGAS-STING Pathway

Autophagy and Protein Quality Control

Therapeutic Targeting Strategies

Kinase Inhibitors

Novel Therapeutic Approaches

Biomarker Potential

Research Directions

Model Systems

Genetic Studies

Summary

See Also

External Links

References

💬 Discussion